Treatment of lower urinary tract dysfunction in patients with multiple sclerosis. European Group on SUDIMS

The endocannabinoid system - current implications for drug development.

Journal of internal medicine·2020

Reduced TRPC6 mRNA levels in the blood cells of patients with Alzheimer's disease and mild cognitive impairment.

Molecular psychiatry·2017

Sulfotransferase 1A3/4 copy number variation is associated with neurodegenerative disease.

The pharmacogenomics journal·2017

Botulinum toxin-A for the treatment of overactive bladder: UK contributions.

Journal of clinical urology·2015

Delta(9) -tetrahydrocannabinol and cannabidiol as potential curative agents for cancer: A critical examination of the preclinical literature.

Clinical pharmacology and therapeutics·2015

Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessment.

Molecular psychiatry·2014

Comparative effectiveness of inebilizumab versus conventional immunotherapies in AQP4-IgG-positive NMOSD: a prospective cohort study with time-varying treatment effects.

Journal of neurology, neurosurgery, and psychiatry·2026

Age and treatment class modify inflammatory risk after disease-modifying therapy discontinuation in older people with MS.

Journal of neurology, neurosurgery, and psychiatry·2026

MRI activity in pre-symptomatic multiple sclerosis: the role of paramagnetic rim lesions beyond the 2024 McDonald diagnostic criteria.

Journal of neurology, neurosurgery, and psychiatry·2026

Prevalence, clinical characteristics and treatment response of tremor in chronic inflammatory demyelinating polyneuropathy.

Journal of neurology, neurosurgery, and psychiatry·2026

Whole-body quantitative muscle MRI in myotonic dystrophy type 2: a sensitive tool for pattern recognition, disease stratification and objective assessment of clinical severity.

Journal of neurology, neurosurgery, and psychiatry·2026

Presymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timing.

Journal of neurology, neurosurgery, and psychiatry·2026

m(6)A RNA Methylation in aging and age-related diseases.

Archives of gerontology and geriatrics·2026

Evaluation of Vamana and Virechana as Interventions to Decelerate the Aging Process in Healthy Adult Volunteers: Protocol for an Exploratory Single-Arm Clinical Trial.

JMIR research protocols·2026

Effect of an Integrated Early Enteral Nutrition Management Protocol on Nutritional Target Attainment in Mechanically Ventilated ICU Patients: A Quasi-Experimental Study Guided by the MRC Framework.

Nursing in critical care·2026

Tuina Attenuates Pain with Reduced Serum Pain- and Inflammation-Related Mediators and p38 MAPK Phosphorylation in Selected Brain Regions in Rats with Knee Osteoarthritis.

Journal of pain research·2026

Twelve-month real-world outcomes of sparsentan in a multicenter Spanish IgA nephropathy cohort.

Clinical kidney journal·2026

Correction: Network pharmacology-based prediction and experimental validation of the anti-hyperuricemic effects of oolong tea polyphenols.

Frontiers in nutrition·2026

Related Experiment Videos

Treatment of lower urinary tract dysfunction in patients with multiple sclerosis. European Group on SUDIMS

Related Concept Videos

The endocannabinoid system - current implications for drug development.

Reduced TRPC6 mRNA levels in the blood cells of patients with Alzheimer's disease and mild cognitive impairment.

Sulfotransferase 1A3/4 copy number variation is associated with neurodegenerative disease.

Botulinum toxin-A for the treatment of overactive bladder: UK contributions.

Delta(9) -tetrahydrocannabinol and cannabidiol as potential curative agents for cancer: A critical examination of the preclinical literature.

Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessment.

Comparative effectiveness of inebilizumab versus conventional immunotherapies in AQP4-IgG-positive NMOSD: a prospective cohort study with time-varying treatment effects.

Age and treatment class modify inflammatory risk after disease-modifying therapy discontinuation in older people with MS.

MRI activity in pre-symptomatic multiple sclerosis: the role of paramagnetic rim lesions beyond the 2024 McDonald diagnostic criteria.

Prevalence, clinical characteristics and treatment response of tremor in chronic inflammatory demyelinating polyneuropathy.

Whole-body quantitative muscle MRI in myotonic dystrophy type 2: a sensitive tool for pattern recognition, disease stratification and objective assessment of clinical severity.

Presymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timing.

m(6)A RNA Methylation in aging and age-related diseases.

Evaluation of Vamana and Virechana as Interventions to Decelerate the Aging Process in Healthy Adult Volunteers: Protocol for an Exploratory Single-Arm Clinical Trial.

Effect of an Integrated Early Enteral Nutrition Management Protocol on Nutritional Target Attainment in Mechanically Ventilated ICU Patients: A Quasi-Experimental Study Guided by the MRC Framework.

Tuina Attenuates Pain with Reduced Serum Pain- and Inflammation-Related Mediators and p38 MAPK Phosphorylation in Selected Brain Regions in Rats with Knee Osteoarthritis.

Twelve-month real-world outcomes of sparsentan in a multicenter Spanish IgA nephropathy cohort.

Correction: Network pharmacology-based prediction and experimental validation of the anti-hyperuricemic effects of oolong tea polyphenols.

Related Experiment Videos

Treatment of lower urinary tract dysfunction in patients with multiple sclerosis. European Group on SUDIMS

Related Concept Videos

Related Articles